234 related articles for article (PubMed ID: 23083992)
1. Refractory celiac disease.
Malamut G; Murray JA; Cellier C
Gastrointest Endosc Clin N Am; 2012 Oct; 22(4):759-72. PubMed ID: 23083992
[TBL] [Abstract][Full Text] [Related]
2. Refractory celiac disease.
Malamut G; Cellier C
Expert Rev Gastroenterol Hepatol; 2014 Mar; 8(3):323-8. PubMed ID: 24502536
[TBL] [Abstract][Full Text] [Related]
3. Refractory coeliac disease.
Malamut G; Cellier C
Curr Opin Oncol; 2013 Sep; 25(5):445-51. PubMed ID: 23942290
[TBL] [Abstract][Full Text] [Related]
4. Monitoring nonresponsive patients who have celiac disease.
Krauss N; Schuppan D
Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
[TBL] [Abstract][Full Text] [Related]
5. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells promote expansion and survival of aberrant TCR-negative intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Schmitz F; Tjon JM; van Bergen J; Koning F
Mol Immunol; 2014 Mar; 58(1):10-6. PubMed ID: 24252355
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic yield of capsule endoscopy in refractory celiac disease.
Barret M; Malamut G; Rahmi G; Samaha E; Edery J; Verkarre V; Macintyre E; Lenain E; Chatellier G; Cerf-Bensussan N; Cellier C
Am J Gastroenterol; 2012 Oct; 107(10):1546-53. PubMed ID: 22964554
[TBL] [Abstract][Full Text] [Related]
8. Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease.
Tuire I; Marja-Leena L; Teea S; Katri H; Jukka P; Päivi S; Heini H; Markku M; Pekka C; Katri K
Am J Gastroenterol; 2012 Oct; 107(10):1563-9. PubMed ID: 22825364
[TBL] [Abstract][Full Text] [Related]
9. DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Tjon JM; Kooy-Winkelaar YM; Tack GJ; Mommaas AM; Schreurs MW; Schilham MW; Mulder CJ; van Bergen J; Koning F
J Immunol; 2011 Jun; 186(11):6304-12. PubMed ID: 21525383
[TBL] [Abstract][Full Text] [Related]
10. The management of complicated celiac disease.
Al-toma A; Verbeek WH; Mulder CJ
Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
[TBL] [Abstract][Full Text] [Related]
11. Refractory celiac disease: epidemiology and clinical manifestations.
Malamut G; Cellier C
Dig Dis; 2015; 33(2):221-226. PubMed ID: 25925926
[TBL] [Abstract][Full Text] [Related]
12. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.
de Mascarel A; Belleannée G; Stanislas S; Merlio C; Parrens M; Laharie D; Dubus P; Merlio JP
Am J Surg Pathol; 2008 May; 32(5):744-51. PubMed ID: 18360280
[TBL] [Abstract][Full Text] [Related]
13. Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II.
Schmitz F; Tjon JM; Lai Y; Thompson A; Kooy-Winkelaar Y; Lemmers RJ; Verspaget HW; Mearin ML; Staal FJ; Schreurs MW; Cupedo T; Langerak AW; Mulder CJ; van Bergen J; Koning F
Gut; 2013 Apr; 62(4):509-19. PubMed ID: 22760007
[TBL] [Abstract][Full Text] [Related]
14. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in refractory coeliac disease: a review.
Ho-Yen C; Chang F; van der Walt J; Mitchell T; Ciclitira P
Histopathology; 2009 Jun; 54(7):783-95. PubMed ID: 18700844
[TBL] [Abstract][Full Text] [Related]
16. [Non-responsive coeliac disease: what to do?].
van Wanrooij RL; Neefjes-Borst EA; von Blomberg BM; Mulder CJ; Bouma G
Ned Tijdschr Geneeskd; 2012; 156(32):A4843. PubMed ID: 22871251
[TBL] [Abstract][Full Text] [Related]
17. Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease.
Olaussen RW; Løvik A; Tollefsen S; Andresen PA; Vatn MH; De Lange T; Bratlie J; Brandtzaeg P; Farstad IN; Lundin KE
Clin Gastroenterol Hepatol; 2005 Sep; 3(9):875-85. PubMed ID: 16234025
[TBL] [Abstract][Full Text] [Related]
18. Refractory Celiac Disease.
Malamut G; Cellier C
Gastroenterol Clin North Am; 2019 Mar; 48(1):137-144. PubMed ID: 30711206
[TBL] [Abstract][Full Text] [Related]
19. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.
Kurppa K; Collin P; Viljamaa M; Haimila K; Saavalainen P; Partanen J; Laurila K; Huhtala H; Paasikivi K; Mäki M; Kaukinen K
Gastroenterology; 2009 Mar; 136(3):816-23. PubMed ID: 19111551
[TBL] [Abstract][Full Text] [Related]
20. A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease.
Hrdlickova B; Mulder CJ; Malamut G; Meresse B; Platteel M; Kamatani Y; Ricaño-Ponce I; van Wanrooij RLJ; Zorro MM; Jan Bonder M; Gutierrez-Achury J; Cellier C; Zhernakova A; Nijeboer P; Galan P; Withoff S; Lathrop M; Bouma G; Xavier RJ; Jabri B; Bensussan NC; Wijmenga C; Kumar V
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):828-837. PubMed ID: 29787419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
